Structure-based Discovery of Cell-Potent Peptidomimetic Inhibitors for Protein N-Terminal Methyltransferase 1.


Journal

ACS medicinal chemistry letters
ISSN: 1948-5875
Titre abrégé: ACS Med Chem Lett
Pays: United States
ID NLM: 101521073

Informations de publication

Date de publication:
11 Mar 2021
Historique:
received: 06 01 2021
accepted: 24 02 2021
entrez: 19 3 2021
pubmed: 20 3 2021
medline: 20 3 2021
Statut: epublish

Résumé

Protein N-terminal methyltransferases (NTMTs) catalyze the methylation of the α-N-terminal amines of proteins starting with an X-P-K/R motif. NTMT1 has been implicated in various cancers and in aging, implying its role as a potential therapeutic target. Through structural modifications of a lead NTMT1 inhibitor,

Identifiants

pubmed: 33738076
doi: 10.1021/acsmedchemlett.1c00012
pmc: PMC7958150
doi:

Types de publication

Journal Article

Langues

eng

Pagination

485-493

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM117275
Pays : United States

Informations de copyright

© 2021 American Chemical Society.

Déclaration de conflit d'intérêts

The authors declare no competing financial interest.

Références

Chembiochem. 2019 Apr 15;20(8):976-984
pubmed: 30479015
Biochem J. 2013 Dec 15;456(3):453-62
pubmed: 24090352
Nat Commun. 2017 Mar 07;8:14678
pubmed: 28266506
Nat Cell Biol. 2007 May;9(5):596-603
pubmed: 17435751
J Proteome Res. 2015 Jun 5;14(6):2575-82
pubmed: 25886813
J Proteome Res. 2013 Sep 6;12(9):4167-75
pubmed: 23978223
J Med Chem. 2020 Sep 10;63(17):9512-9522
pubmed: 32689795
J Med Chem. 2020 Aug 13;63(15):8419-8431
pubmed: 32605369
FEBS Lett. 1976 Sep 15;68(1):115-8
pubmed: 786732
Oncotarget. 2015 May 20;6(14):12248-63
pubmed: 25909287
RSC Adv. 2016;6(8):6768-6771
pubmed: 27588169
J Biol Chem. 2015 May 1;290(18):11601-10
pubmed: 25771539
J Med Chem. 2019 Apr 11;62(7):3773-3779
pubmed: 30883119
Genes Dev. 2015 Nov 15;29(22):2343-8
pubmed: 26543161
Mech Ageing Dev. 2015 Mar;146-148:42-52
pubmed: 25843235
Commun Biol. 2018 Nov 2;1:183
pubmed: 30417120
J Biol Chem. 2014 Jun 6;289(23):16046-56
pubmed: 24753253
Org Biomol Chem. 2015 Apr 14;13(14):4149-54
pubmed: 25712161
Nature. 2010 Aug 26;466(7310):1125-8
pubmed: 20668449

Auteurs

Dongxing Chen (D)

Department of Medicinal Chemistry and Molecular Pharmacology, Purdue Institute for Drug Discovery, Purdue University Center for Cancer Research, Purdue University, West Lafayette, Indiana 47907, United States.

Guangping Dong (G)

Department of Medicinal Chemistry and Molecular Pharmacology, Purdue Institute for Drug Discovery, Purdue University Center for Cancer Research, Purdue University, West Lafayette, Indiana 47907, United States.

Youchao Deng (Y)

Department of Medicinal Chemistry and Molecular Pharmacology, Purdue Institute for Drug Discovery, Purdue University Center for Cancer Research, Purdue University, West Lafayette, Indiana 47907, United States.

Nicholas Noinaj (N)

Department of Biological Sciences, Markey Center for Structural Biology, and the Purdue Institute of Inflammation, Immunology and Infectious Disease, Purdue University, West Lafayette, Indiana 47907, United States.

Rong Huang (R)

Department of Medicinal Chemistry and Molecular Pharmacology, Purdue Institute for Drug Discovery, Purdue University Center for Cancer Research, Purdue University, West Lafayette, Indiana 47907, United States.

Classifications MeSH